Heating technology for malignant tumors: A review
The therapeutic application of heat is very effective in cancer treatment. Both hyperthermia,
ie, heating to 39–45° C to induce sensitization to radiotherapy and chemotherapy, and …
ie, heating to 39–45° C to induce sensitization to radiotherapy and chemotherapy, and …
[HTML][HTML] Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?
Colorectal cancer commonly metastasizes. The liver is the most frequent site of metastases
and dominates the length of survival for this disease. As surgical and systemic therapies …
and dominates the length of survival for this disease. As surgical and systemic therapies …
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases …
D Goéré, O Glehen, F Quenet, JM Guilloit… - The Lancet …, 2020 - thelancet.com
Background Diagnosis and treatment of colorectal peritoneal metastases at an early stage,
before the onset of signs, could improve patient survival. We aimed to compare the survival …
before the onset of signs, could improve patient survival. We aimed to compare the survival …
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
CEL Klaver, DD Wisselink, CJA Punt… - The lancet …, 2019 - thelancet.com
Background Nearly a quarter of patients with locally advanced (T4 stage) or perforated colon
cancer are at risk of developing peritoneal metastases, often without curative treatment …
cancer are at risk of developing peritoneal metastases, often without curative treatment …
The role of hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei after cytoreductive surgery
S Kusamura, F Barretta, Y Yonemura… - JAMA …, 2021 - jamanetwork.com
Importance Studies on the prognostic role of hyperthermic intraperitoneal chemotherapy
(HIPEC) in pseudomyxoma peritonei (PMP) are currently not available. Objectives To …
(HIPEC) in pseudomyxoma peritonei (PMP) are currently not available. Objectives To …
Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical …
JM Foster, R Sleightholm, A Patel, V Shostrom… - JAMA network …, 2019 - jamanetwork.com
Importance Currently, rates of referral of patients with peritoneal metastasis in the United
States who qualify for cytoreductive surgery combined with hyperthermic intraperitoneal …
States who qualify for cytoreductive surgery combined with hyperthermic intraperitoneal …
Small bowel adenocarcinoma, version 1.2020, NCCN clinical practice guidelines in oncology
AB Benson, AP Venook, MM Al-Hawary… - Journal of the National …, 2019 - jnccn.org
Small bowel adenocarcinoma (SBA) is a rare malignancy of the gastrointestinal tract that
has increased in incidence across recent years. Often diagnosed at an advanced stage …
has increased in incidence across recent years. Often diagnosed at an advanced stage …
GECOP-MMC: Phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete …
F Pereira, A Serrano, I Manzanedo, E Pérez-Viejo… - BMC cancer, 2022 - Springer
Abstract Background The French PRODIGE 7 trial, published on January 2021, has raised
doubts about the specific survival benefit provided by HIPEC with oxaliplatin 460 mg/m2 (30 …
doubts about the specific survival benefit provided by HIPEC with oxaliplatin 460 mg/m2 (30 …
HIPEC with oxaliplatin for colorectal peritoneal metastasis: the end of the road?
W Ceelen - European Journal of Surgical Oncology, 2019 - Elsevier
In patients with colorectal peritoneal metastases (PM), the use of cytoreductive surgery
(CRS) and HIPEC with oxaliplatin (OX) is increasingly used. The results of the recently …
(CRS) and HIPEC with oxaliplatin (OX) is increasingly used. The results of the recently …
[HTML][HTML] Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: A systematic review
RC Auer, D Sivajohanathan, J Biagi, J Conner… - European Journal of …, 2020 - Elsevier
The purpose of the present review was to describe evidence-based indications for
hyperthermic intraperitoneal chemotherapy (HIPEC), with cytoreductive surgery (CRS), in …
hyperthermic intraperitoneal chemotherapy (HIPEC), with cytoreductive surgery (CRS), in …